Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prognostic Significance of Tumor-Infiltrating Natural Killer Cells in Solid Tumors: A Systematic Review and Meta-Analysis
Shuo Zhang, Weijian Liu, Binwu Hu, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 71

Showing 26-50 of 71 citing articles:

Immune predictors of response to immune checkpoint inhibitors in mismatch repair-deficient endometrial cancer
Juan Francisco Grau-Béjar, E. Yaniz Galende, Qinghe Zeng, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 7, pp. e009143-e009143
Open Access | Times Cited: 3
Postoperative Natural Killer Cell Dysfunction: The Prime Suspect in the Case of Metastasis Following Curative Cancer Surgery
Marisa Market, Gayashan Tennakoon, Rebecca C. Auer
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11378-11378
Open Access | Times Cited: 26
The unique role of innate lymphoid cells in cancer and the hepatic microenvironment
Sophie Curio, Gabrielle T. Belz
Cellular and Molecular Immunology (2022) Vol. 19, Iss. 9, pp. 1012-1029
Open Access | Times Cited: 15
Intratumoral NKp46+ natural killer cells are spatially distanced from T and MHC-I+ cells with prognostic implications in soft tissue sarcoma
Sylvia M. Cruz, Cyrus Sholevar, Sean J. Judge, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
High-Dimensional Analyses Reveal IL15 Enhances Activation of Sipuleucel-T Lymphocyte Subsets and Reverses Immunoresistance
Muhammad A. Saeed, Bo Peng, Kevin Kim, et al.
Cancer Immunology Research (2024) Vol. 12, Iss. 5, pp. 559-574
Closed Access | Times Cited: 2
Preventing postsurgical colorectal cancer relapse: A hemostatic hydrogel loaded with METTL3 inhibitor for CAR-NK cell therapy
Zilin Tan, Liangjie Tian, Yang Luo, et al.
Bioactive Materials (2024) Vol. 44, pp. 236-255
Open Access | Times Cited: 2
NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications
Paolo Sportoletti, Filomena De Falco, Beatrice Del Papa, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6665-6665
Open Access | Times Cited: 19
The Prognostic Value of Natural Killer Cells and Their Receptors/Ligands in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
Jun-Shuai Xue, Zi‐Niu Ding, Guang-Xiao Meng, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
TLR3 Expression is a Potential Prognosis Biomarker and Shapes the Immune-Active Tumor Microenvironment in Esophageal Squamous Cell Carcinoma
Ruibing Su, Lijun Cai, Pan Xiong, et al.
Journal of Inflammation Research (2022) Vol. Volume 15, pp. 1437-1456
Open Access | Times Cited: 12
Synergistic treatment strategy: combining CAR-NK cell therapy and radiotherapy to combat solid tumors
Jie He, Yan Yushan, Jun Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Natural Compounds as Metabolic Modulators of the Tumor Microenvironment
Ana S. Dias, Luísa A. Helguero, Catarina R. Almeida, et al.
Molecules (2021) Vol. 26, Iss. 12, pp. 3494-3494
Open Access | Times Cited: 16
Combining radiotherapy and NK cell-based therapies: The time has come
Jérémy Baude, Emeric Limagne, Riad Ladjohounlou, et al.
International review of cell and molecular biology (2023), pp. 31-60
Closed Access | Times Cited: 6
Prostaglandin E₂ impacts multiple stages of the natural killer cell antitumor immune response
Chloe Patterson, Khodor S. Hazime, Santiago Zelenay, et al.
European Journal of Immunology (2023) Vol. 54, Iss. 2
Open Access | Times Cited: 5
USH2A Mutation is Associated With Tumor Mutation Burden and Antitumor Immunity in Patients With Colon Adenocarcinoma
Yuanyuan Sun, Li Long, Wenchao Yao, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 13
Real-time ex vivo monitoring of NK cell migration toward obesity-associated oesophageal adenocarcinoma following modulation of CX3CR1
Eimear Mylod, Fiona O’Connell, Noel E. Donlon, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Characterization of HIF-1α Knockout Primary Human Natural Killer Cells including Populations in Allogeneic Glioblastoma
Tsutomu Nakazawa, Takayuki Morimoto, Ryosuke Maeoka, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5896-5896
Open Access | Times Cited: 1
Characterization of tumor-infiltrating lymphocytes and their spatial distribution in triple-negative breast cancer
Eunkyung Han, Hye Yeon Choi, Hyun Jung Kwon, et al.
Breast Cancer Research (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 1
The Role of Innate Immune Cells in Tumor Invasion and Metastasis
Yukuan Huang, Rita A. Busuttil, Alex Boussioutas
Cancers (2021) Vol. 13, Iss. 23, pp. 5885-5885
Open Access | Times Cited: 12
Suppression of CD56bright NK cells in breast cancer patients is associated with the PD-1 and TGF-βRII expression
Elaheh Arianfar, Seyed Reza Khandoozi, Saeed Mohammadi, et al.
Clinical & Translational Oncology (2022) Vol. 25, Iss. 3, pp. 841-851
Closed Access | Times Cited: 7
KLRF1, a novel marker of CD56bright NK cells, predicts improved survival for patients with locally advanced bladder cancer
Neelam Mukherjee, Niannian Ji, Xi Tan, et al.
Cancer Medicine (2022) Vol. 12, Iss. 7, pp. 8970-8980
Open Access | Times Cited: 7
The Dual Role of Innate Lymphoid and Natural Killer Cells in Cancer. from Phenotype to Single-Cell Transcriptomics, Functions and Clinical Uses
Stefania Roma, Laura Carpen, Alessandro Raveane, et al.
Cancers (2021) Vol. 13, Iss. 20, pp. 5042-5042
Open Access | Times Cited: 9
Augmenting Granzyme B–Expressing NK Cells by Invariant NKT Ligand–Loaded APCs in Patients with Postoperative Early Stage Non–Small Cell Lung Cancer: Results of a Randomized Phase II Study
Tomonori Iyoda, Kanako Shimizu, Masami Kawamura, et al.
ImmunoHorizons (2023) Vol. 7, Iss. 1, pp. 1-16
Open Access | Times Cited: 3
The Prognostic Significance of MACC1 Expression in Breast Cancer and Its Relationship to Immune Cells in the Tumor Microenvironment and Patient Survival
Dina A. Ali, Dina M. El‐Guindy, Mohamed A. El-Rashidy, et al.
Medicina (2021) Vol. 57, Iss. 9, pp. 934-934
Open Access | Times Cited: 8
Prospects and Advances in Adoptive Natural Killer Cell Therapy for Unmet Therapeutic Needs in Pediatric Bone Sarcomas
Halin Bareke, Adrián Ibáñez-Navarro, Pilar Guerra‐García, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8324-8324
Open Access | Times Cited: 2
Comprehensive analysis of the prognostic values and immune implication of ESYT3 in lung adenocarcinoma
Xuedong Li, Jianlin Chen, Jie Meng
Medicine (2023) Vol. 102, Iss. 35, pp. e34557-e34557
Open Access | Times Cited: 2

Scroll to top